Expert consensus on the clinical application of immunotherapy in breast cancer: 2024 [0.03%]
中国乳腺癌免疫治疗临床应用专家共识（2024年版）
Kun Wang,Jin Yang,Biyun Wang et al.
Kun Wang et al.
Background: Significant progress has been made in immunotherapy of breast cancer (BC) with the approval of multiple immune checkpoint inhibitors (ICIs), particularly in early and metastatic triple-negative breast cancer (...
A case report of low-dose apatinib in the treatment of advanced triple-negative breast cancer [0.03%]
阿帕替尼治疗三阴性乳腺癌1例报告
Ye Lv,Huiqiang Zhang,Yanjiao Zhao et al.
Ye Lv et al.
Background: The current study shows that the incidence rate of triple-negative breast cancer accounts for 10-17% of invasive ductal carcinoma of the breast. There is no specific treatment target, the age of onset is relat...
TORCHLIGHT trial, brightening the life of more patients with advanced triple-negative breast cancer [0.03%]
“火炬试验”为更多晚期三阴性乳腺癌患者带来生命曙光
Huiqiang Zhang,Xiao Jin,Li Bian
Huiqiang Zhang
Toripalimab (JS001) is a monoclonal antibody against programmed cell death-1 (PD-1), independently developed by Shanghai Junshi Biosciences Co., LTD, which is the first domestic original PD-1 inhibitor approved in China. TORCHLIGHT is the f...
Metabolomics combined with mathematical analysis reveals metabolic pathways specific to metastatic cancers [0.03%]
结合数学分析的代谢组学揭示了转移性癌症特有的代谢途径
Shinya Sato,Toshinari Yamashita
Shinya Sato
Breast fat grafting and cancer: a systematic review of the science behind enhancements and concerns [0.03%]
乳房脂肪填充与癌症：增强与担忧背后的科学系统性综述
Denis Souto Valente,Pedro Bins Ely,Lucas Kieling et al.
Denis Souto Valente et al.
Background: Autologous fat transfer (AFT) is gaining popularity in breast surgery, offering a natural-looking and minimally invasive approach for augmentation, reconstruction, and contouring. However, concerns about its i...
Internal mammary lymphadenopathy in breast cancer: a narrative review and update [0.03%]
乳腺癌的内乳淋巴结病变：叙事性综述与更新
Kathryn M Eckert,Judy C Boughey,Mara A Piltin
Kathryn M Eckert
Background and objective: While the axillary nodal basin is the most common lymphatic drainage pathway of the breast, the internal mammary (IM) lymph node chain plays a significant role in breast cancer staging and treatm...
Narrative review on advancing breast cancer treatment: harnessing the power of PD-1/PD-L1 inhibitors for improved patient outcomes [0.03%]
关于乳腺癌治疗进展的故事性评审：利用PD-1/PD-L1抑制剂改善患者预后
Fan Zhang,Shu-Sen Wang
Fan Zhang
Background and objective: Cancer immunotherapy has significantly advanced the field of oncology, providing novel therapeutic strategies for various malignancies, including breast cancer. The programmed cell death protein ...
Circulating tumor cells et al.: towards a comprehensive liquid biopsy approach in breast cancer [0.03%]
循环肿瘤细胞等：向乳腺癌全面液体活检方法迈进
Eleonora Nicolò,Caterina Gianni,Letizia Pontolillo et al.
Eleonora Nicolò et al.
Liquid biopsy has emerged as a crucial tool in managing breast cancer (BC) patients, offering a minimally invasive approach to detect circulating tumor biomarkers. Until recently, the majority of the studies in BC focused on evaluating a si...
Implications of tumor-infiltrating lymphocytes in early-stage triple-negative breast cancer: clinical oncologist perspectives [0.03%]
肿瘤浸润淋巴细胞在早期三阴性乳腺癌中的意义：临床肿瘤学家的视角
Mahira Lopes Rosa,Tomas Reinert,Maiane Maria Pauletto et al.
Mahira Lopes Rosa et al.
Breast cancer (BC) is the most common neoplasm in women worldwide and one of the leading causes of female death. The triple-negative subtype, characterized by the absence of hormone receptor (HR) and human epidermal growth factor receptor 2...
A new pathological assessment method to assess residual lesions after neoadjuvant chemotherapy for breast cancer, residual disease in breast and nodes combined with Ki-67 (RDBN-K) [0.03%]
乳腺癌新辅助化疗后病残评估的新方法，联合Ki-67的乳房和腋窝残余病变（RDBN-K）评估
Ruoqi Han,Yanqi Ma,Zhikun Liu et al.
Ruoqi Han et al.
Background: The accurate assessment of residual tumor tissue after neoadjuvant chemotherapy (NAC) for breast cancer is closely related to the subsequent treatment and prognosis of patients. The objective of this study is ...